|
Kabra Drugs Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
46.09 Cr.
|
P/BV
|
1.87
|
Book Value (Rs.)
|
10.40
|
|
52 Week High/Low (Rs.)
|
23/10
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Employees Cost | 0.44 | 0.25 | 0.22 | 0.18 | 0.13 |
| Depreciation | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.33 | 0.69 | 0.26 | 0.07 | 0.08 |
| Total Expenses | 0.78 | 0.94 | 0.48 | 0.26 | 0.20 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.78 | -0.94 | -0.48 | -0.26 | -0.20 |
| Other Income | 0.64 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/L Before Interest, Excpt. Items & Tax | -0.14 | -0.94 | -0.48 | -0.26 | -0.20 |
| P/L Before Exceptional Items & Tax | -0.14 | -0.94 | -0.48 | -0.26 | -0.20 |
| P/L Before Tax | -0.14 | -0.94 | -0.48 | -0.26 | -0.20 |
| P/L After Tax from Ordinary Activities | -0.14 | -0.94 | -0.48 | -0.26 | -0.20 |
| Net Profit/Loss For the Period | -0.14 | -0.94 | -0.48 | -0.26 | -0.20 |
| | | | | | |
| Equity Share Capital | 23.71 | 10.08 | 4.39 | 4.39 | 4.39 |
| Reserves And Surplus | 0.00 | 0.00 | -5.86 | 0.00 | -5.12 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.06 | -9.35 | -1.09 | -0.58 | -0.46 |
| Diluted EPS (Rs.) | (0.06) | -9.35 | (1.09) | -0.58 | (0.46) |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.06 | -9.35 | -1.09 | -0.58 | -0.46 |
| Diluted EPS (Rs.) | 0.00 | -9.35 | 0.00 | -0.58 | 0.00 |
